A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Clinical trial NCT01149291 · COMPLETED

Trial details

NCT number: NCT01149291
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Study type: OBSERVATIONAL

Secondary Hyperparathyroidism End Stage Renal Disease

Start date: 2011-07-01
Primary completion: 2014-12-01
Enrollment: 511

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.